Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Cancer control domain
    • 1. Prevention
      • Smoking prevalence
      • Smoking behaviours in current cancer patients
      • Smoking cessation
      • Second-hand smoke exposure
      • Geographic variation in lung cancer risk
      • Alcohol consumption
      • Adult overweight and obesity
      • Active transportation
      • Physical inactivity
      • Human papillomavirus (HPV) vaccination
      • Fruit and vegetable consumption
      • Geographic variation in colorectal cancer risk
    • 2. Screening
      • Cervical cancer screening
      • Breast cancer screening
      • Colorectal cancer screening
      • PSA testing
      • Screening in underserved populations
    • 3. Diagnosis
      • Breast cancer diagnosis wait times
      • Colorectal cancer diagnosis wait times
      • Capture of stage
      • Stage distribution
      • Prostate risk profile
    • 4. Treatment
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
        • Breast cancer resections that are mastectomies
        • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
        • Prostate wait times for surgery
        • Radical prostatectomy: open versus laparoscopic surgery
      • Radiation therapy
        • Radiation therapy wait times
        • Radiation therapy utilization and capacity
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
        • Post-operative radiation therapy for patients with stage I or II breast cancer
        • Prostate wait times for radiation therapy
        • Prostate patterns of care: radiation and surgical treatment
      • Systemic therapy
        • Post-operative chemotherapy for stage III colon cancer patients
        • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
    • 5. Person-Centred Perspective
      • Screening for distress
      • Patient satisfaction
      • Place of death
      • Prostate access to palliative radiation
    • 6. Research
      • Adult clinical trial participation
      • Prostate clinical trials participation
      • Pediatric clinical trial participation
      • Cancer research investment
      • Prostate cancer research investment
    • 7. Appropriateness
      • Breast cancer screening outside of guidelines
      • Breast cancer mastectomies done as day surgery
      • Intensive care use in the last two weeks of life
    • 8. Long-term outcomes
      • Breast cancer
      • Lung cancer
      • Colorectal cancer
      • Prostate cancer
      • Pancreatic cancer
      • Five-year net survival by income quintile for several cancers in Canada
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
System Performance Logo
System Performance
  • About
  • Reports
  • Français
  • Home
  • Disease sites
  • Colorectal
  • Five-year net survival by income quintile for several cancers in Canada

Five-year net survival by income quintile for several cancers in Canada

  • Charts and Tables

    Charts and Tables

    Figure 8.24

    Five-year net survival by patient income quintile for six cancers, age-standardized† — 2004–09 diagnosis years

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    † Age-standardized using the International Cancer Survival Standard weights.

    Newfoundland and Labrador, the Northwest Territories, Nunavut and Yukon were not included in analysis by income quintile (see Methods).

    Childhood leukemia: ages 0–14 years. All other cancers: ages 15–99 years.

    Data source: Provincial cancer agencies and programs.

    Data Table

    Cancer siteIncome quintileNet survival rate (%)Lower bound of 95% confidence intervalUpper bound of 95% confidence interval
    BreastQ1 (lowest income)82.881.783.8
    BreastQ284.183.185.1
    BreastQ385.584.486.6
    BreastQ485.784.586.8
    BreastQ5 (highest income)87.986.889.1
    ColorectalQ1 (lowest income)59.358.360.4
    ColorectalQ261.660.562.6
    ColorectalQ362.961.864.0
    ColorectalQ463.962.865.0
    ColorectalQ5 (highest income)65.364.266.4
    LungQ1 (lowest income)16.115.416.8
    LungQ216.916.217.7
    LungQ318.117.418.9
    LungQ417.716.918.6
    LungQ5 (highest income)18.918.019.8
    ProstateQ1 (lowest income)89.388.390.4
    ProstateQ289.888.890.8
    ProstateQ391.290.292.1
    ProstateQ491.990.992.9
    ProstateQ5 (highest income)93.692.794.5
    StomachQ1 (lowest income)23.721.725.8
    StomachQ224.522.526.5
    StomachQ325.723.527.8
    StomachQ423.020.725.2
    StomachQ5 (highest income)24.422.026.8
    Childhood LeukemiaQ1 (lowest income)92.488.196.7
    Childhood LeukemiaQ288.280.995.5
    Childhood LeukemiaQ391.087.294.7
    Childhood LeukemiaQ490.485.795.1
    Childhood LeukemiaQ5 (highest income)92.187.596.7

    + Expand Table

    † Age-standardized using the International Cancer Survival Standard weights.

    Newfoundland and Labrador, the Northwest Territories, Nunavut and Yukon were not included in analysis by income quintile (see Methods).

    Childhood leukemia: ages 0–14 years. All other cancers: ages 15–99 years.

    Data source: Provincial cancer agencies and programs.

  • Data specifications

    Data specifications

    This analysis was conducted by the CONCORD-2 Programmer, as a sub-analysis of the CONCORD-2 study that was funded by the Canadian Partnership Against Cancer. Details on methodologies for calculating survival were published in The Lancet in 2015 (http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736%2814%2962038-9.pdf). For specific details related to the survival by income quintile analysis, please refer to the methods section in this special feature section.

  • Related indicators

    Related Indicators

    Breast cancer

    Incidence rates for breast cancer in women, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year
    View this indicator
    Lung cancer

    Incidence rates for lung cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year
    View this indicator
    Colorectal cancer

    Incidence and mortality rates† for colorectal cancer, by sex, Canada — from 1992 to 2014
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow Project
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation